Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
38 participants
OBSERVATIONAL
2017-05-05
2020-03-12
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Marijuana's Impact on Alcohol Motivation and Consumption
NCT02983773
Decisions During Drinking
NCT06978140
Assessing Habitual, Goal-Directed, and Pavlovian Influences in Alcohol Use Disorder
NCT06701500
Mechanisms of Risky Alcohol Use in Young Adults: Linking Sleep to Reward- and Stress-Related Brain Function
NCT05684094
Cannabinoid Receptor Function & Alcoholism
NCT00624715
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
P
for cannabis
No interventions assigned to this group
C
for the control group
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Absence of consumption of cannabis and tobacco for 1 year and absence of substance use disorder in history
* Matching in age and sex to the group consumers of cannabis
* Early consumers of cannabis (at the beginning of the consumptions before 16 years)
* Man or woman of age between 18 and 50 years old
* Statement of more than three consumptions a day of cannabis for at least one year and consumption of cannabis having begun before the age of 16 years.
* Urinary analysis is positive for the presence of cannabis
* Positive auto-questionnaire CAST: 2 positive answers to CAST questionnaire
* Hospitalized or not
Exclusion Criteria
* History of cranial trauma with loss of consciousness.
* substance use disorder except the substance tested in the protocol (cannabis).
* Invalidating sensory disorders in particular visual: glaucoma, any retinal pathology. Visual acuteness 0.8
* History of general anesthesia in the previous 3 months the study
* Any evolutionary neurological or psychiatric pathology
* Subject under guardianship
* pregnancy
* Feeding
18 Years
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University Hospital, Strasbourg, France
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Laurence LALANNE-TONGIO, MD
Role: PRINCIPAL_INVESTIGATOR
Hôpitaux Universitaires de Strasbourg
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Les Hôpitaux Universitaires de Strasbourg
Strasbourg, Alsace, France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
6526
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.